Stock Track | Staar Surgical Shares Jump After Beating Q3 Earnings Estimates

Stock Track10-31

Staar Surgical Co.'s stock soared 5.12% in extended trading on Tuesday after the company reported better-than-expected third-quarter earnings and revenue, fueled by strong demand for its implantable lenses.

The eye surgery products maker posted Q3 revenue of $88.59 million, surpassing analysts' consensus estimate of $86.9 million. Adjusted earnings per share came in at $0.33, significantly beating Wall Street's projection of $0.17 per share.

The company's strong Q3 performance was driven by robust sales across its product portfolio. Staar Surgical's gross margin also improved to 77.3% in the quarter, up from 76.3% a year earlier. Looking ahead, the company raised its full-year revenue guidance to a range of $340 million to $345 million, reflecting continued growth momentum.

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap

Leave a comment

{"i18n":{"language":"en_US"},"isChannel":false,"data":{"share":"https://ttm.financial/m/news/1189314664?lang=en_US&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2024-10-31 05:24","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"1189314664","market":"us","top_or_hot":-1,"title":"Stock Track | Staar Surgical Shares Jump After Beating Q3 Earnings Estimates","media":"Stock Track","content":"<p>Staar Surgical Co.'s stock soared 5.12% in extended trading on Tuesday after the company reported better-than-expected third-quarter earnings and revenue, fueled by strong demand for its implantable lenses.</p>\n\n<p>The eye surgery products maker posted Q3 revenue of $88.59 million, surpassing analysts' consensus estimate of $86.9 million. Adjusted earnings per share came in at $0.33, significantly beating Wall Street's projection of $0.17 per share.</p>\n\n<p>The company's strong Q3 performance was driven by robust sales across its product portfolio. Staar Surgical's gross margin also improved to 77.3% in the quarter, up from 76.3% a year earlier. Looking ahead, the company raised its full-year revenue guidance to a range of $340 million to $345 million, reflecting continued growth momentum.</p>","source":"ai_movement_en","html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Stock Track | Staar Surgical Shares Jump After Beating Q3 Earnings Estimates</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nStock Track | Staar Surgical Shares Jump After Beating Q3 Earnings Estimates\n</h2>\n\n<h4 class=\"meta\">\n\n2024-10-31 05:24 北京时间&nbsp;&nbsp;&nbsp;<strong>Stock Track</strong>\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>Staar Surgical Co.'s stock soared 5.12% in extended trading on Tuesday after the company reported better-than-expected third-quarter earnings and revenue, fueled by strong demand for its implantable ...</p>\n\n<a href=\"\">Source Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"STAA","symbol_name":"STAAR Surgical Company","start_time":0,"source_url":"","article_id":"1189314664","we_media_id":"1086803395","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=1189314664","pubTimestamp":1730323479,"sourceInfo":{"source_id":"ai_movement_en","name":"Stock Track"},"weMediaInfo":{"media_name":"Stock Track","introduction":"Track stock‘s movements and relevant news","home_visible":1,"id":"1086803395","head_image":"https://static.tigerbbs.com/a81accab1e7ee4144dc051f71903a390"},"summary":"Staar Surgical Co.'s stock soared 5.12% in extended trading on Tuesday after the company reported better-than-expected third-quarter earnings and revenue, fueled by strong demand for its implantable lenses.The eye surgery products maker posted Q3 revenue of $88.59 million, surpassing analysts' consensus estimate of $86.9 million. Adjusted earnings per share came in at $0.33, significantly beating Wall Street's projection of $0.17 per share.The company's strong Q3 performance was driven by robust","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"en","relate_stocks":{"STAA":"STAAR Surgical Company"},"translate_title":"股票追踪Staar Surgical股价在超出第三季度盈利预期后上涨","themeId":"","isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"STAA":1},"content_text":"Staar Surgical Co.'s stock soared 5.12% in extended trading on Tuesday after the company reported better-than-expected third-quarter earnings and revenue, fueled by strong demand for its implantable lenses.\nThe eye surgery products maker posted Q3 revenue of $88.59 million, surpassing analysts' consensus estimate of $86.9 million. Adjusted earnings per share came in at $0.33, significantly beating Wall Street's projection of $0.17 per share.\nThe company's strong Q3 performance was driven by robust sales across its product portfolio. Staar Surgical's gross margin also improved to 77.3% in the quarter, up from 76.3% a year earlier. Looking ahead, the company raised its full-year revenue guidance to a range of $340 million to $345 million, reflecting continued growth momentum.","kind":"news","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"1","news_tag":"movement","news_rank":0,"symbols":[],"gpt_button":1},"commentList":[],"isCommentEnd":true,"newsSizeData":{"likeSize":0,"commentSize":0,"repostSize":0,"favoriteSize":0,"likeStatus":false,"favoriteStatus":false},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":true,"deviceId":"web-server-community-laohu8-v3","version":"4.29.3","shortVersion":"4.29.3","platform":"web","vendor":"web","appName":"ttm","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"href":"/m/news/1189314664"}